Analysis of cAMP RI alpha mRNA expression in breast cancer: evaluation of quantitative polymerase chain reaction for routine use
1996

Measuring mRNA Levels in Breast Cancer Using PCR

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): JMS Bartlett, MJ Hulme, WR Miller

Primary Institution: University Department of Surgery, Glasgow Royal Infirmary; ICRF Medical Oncology Unit, Western General Hospital

Hypothesis

Can quantitative PCR be effectively used to measure mRNA levels of cAMP RI alpha in breast cancer samples?

Conclusion

The study established that quantitative PCR can accurately measure mRNA levels in breast cancer, demonstrating significant changes in expression.

Supporting Evidence

  • Quantitative PCR demonstrated clear changes in mRNA levels in patient samples.
  • The technique showed intra-assay variations of 16.2% and interassay variations of 9.3%.
  • Values altered by 50% or more represent true changes in mRNA levels.
  • Six out of twelve patients showed significant decreases in RI alpha mRNA during treatment.

Takeaway

This study shows that scientists can use a special test called PCR to see how much of a certain gene is in breast cancer samples, which can help doctors understand the disease better.

Methodology

The study used quantitative PCR to measure mRNA levels, validating the technique with quality control measures.

Limitations

The technique may not clearly separate values that vary by less than 50% within assays.

Participant Demographics

Breast cancer patients, specific demographics not provided.

Statistical Information

P-Value

p<0.05

Confidence Interval

95%

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication